Talimogene Laherparepvec
Amgen
['talimogene', 'melanoma', 'amgen']
 showcased the phase ii trial result of talimogene laherparepvec (t-vec) neoadjuvant treatment (tx) plus surgery vs immediate surgery in resectable stage iiib-ivm1a melanoma (mel) at the 2022. explore more at: #esmo2022 #esmo #esmo22 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry